Video Experimental Relacionado
Updated: Aug 15, 2026
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Estructura del inhibidor de la cinasa dependiente de la ciclina p19Ink4dd
F Y Luh1, S J Archer, P J Domaille
1Cambridge Centre for Molecular Recognition, Department of Biochemistry, University of Cambridge, UK.
Nature
|November 14, 1997
Resumen
La estructura de p19Ink4d revela cómo las mutaciones en las proteínas Ink4 interrumpen las vías del cáncer. Este hallazgo ayuda en el diseño de nuevas terapias contra el cáncer dirigidas a la vía Rb.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Biología Estructural Biología estructural.
Sus antecedentes:
- El cáncer con frecuencia implica la interrupción de las vías supresoras de tumores, particularmente las que involucran a p53 y Rb.
- La vía Rb regula la progresión del ciclo celular y a menudo se altera en el cáncer a través de mutaciones en proteínas clave como Rb, ciclina D1, Cdk4 y p16Ink4a.
Objetivo del estudio:
- Para determinar la estructura de la proteína p19Ink4d utilizando la espectroscopia de RMN.
- Para entender cómo las mutaciones en p16Ink4a conducen a la pérdida de la función.
- Proponer un modelo para las interacciones Ink4-cyclin-Cdk para el desarrollo terapéutico.
Principales métodos:
- Espectroscopia de Resonancia Magnética Nuclear (RMN) para determinar la estructura de las proteínas.
- Análisis de las mutaciones asociadas al cáncer en p16Ink4a.a.
- Modelado estructural de las interacciones de las proteínas Ink4.
Principales resultados:
- Se aclaró la estructura de RMN de p19Ink4d.
- El estudio sugiere que las mutaciones de pérdida de función en p16Ink4a a menudo son el resultado de un mal plegamiento de la proteína o de su insolubilidad.
- Se propuso un modelo para la interacción de la proteína Ink4 con los complejos ciclina-Cdk.
Conclusiones:
- La estructura determinada de p19Ink4d proporciona información sobre la familia Ink4 de inhibidores de la cinasa dependientes de la ciclina (CDKI).
- Comprender las consecuencias estructurales de las mutaciones es crucial para la terapia del cáncer.
- El modelo de interacción propuesto puede guiar el diseño de nuevas terapias contra el cáncer dirigidas a la vía Rb.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...